• Pharma
  • May 22, 2025
  • 525 views
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

HYDERABAD: Vaccine maker Bharat Biotech on Wednesday said its oral cholera vaccine, Hillchol, successfully completed Phase III clinical trials demonstrating efficacy against both Ogawa and Inaba serotypes. The Hyderabad-based vaccine…